These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3452243)

  • 21. Selected problems in immunosuppressive therapy.
    Rondio H
    Mater Med Pol; 1974; 6(1):34-40. PubMed ID: 4613962
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cyclosporin in autoimmune diseases].
    Follath F; Fontana A; Leumann E; Michel BA; Miescher PA; Schreier M; Schroeder M; Wenk M
    Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1232-9. PubMed ID: 8052828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell targeted therapies in autoimmune diseases.
    Isenberg DA
    J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glomerulonephritis in systemic lupus erythematosus].
    Belovezhdov N
    Vutr Boles; 1984; 23(1):1-9. PubMed ID: 6203232
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunology of auto-immune disorders].
    Berthaux P
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):165-73. PubMed ID: 4543895
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modification of in vitro immune mechanisms by various glucocorticosteroid preparations--studies of lymphocytes in healthy probands and autoimmune patients].
    Jahn S; Krohm P; Volk HD; Kiessig S; Grunow R; von Baehr R
    Z Gesamte Inn Med; 1987 Mar; 42(6):160-3. PubMed ID: 3496720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel and immune system.
    Javeed A; Ashraf M; Riaz A; Ghafoor A; Afzal S; Mukhtar MM
    Eur J Pharm Sci; 2009 Nov; 38(4):283-90. PubMed ID: 19733657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The mechanism of action of immunomodulating preparations ( an analysis of their therapeutic effect in a model of experimental cardiomyopathy].
    Groppa LG; Kobets VA; Andreev IuL
    Revmatologiia (Mosk); 1991; (3):30-2. PubMed ID: 1812560
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thymogen in the treatment of type-1 diabetes mellitus].
    Zhuk EA; Galenok VA
    Ter Arkh; 1996; 68(10):12-4. PubMed ID: 9026934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunopathogenic aspects and principles of immunomodulation therapy in autoimmune and chronic connective tissue diseases].
    Dobloug JH; Førre O; Mellbye OJ; Refsum SB; Christoffersen T
    Tidsskr Nor Laegeforen; 1983 Apr; 103(10):823-8. PubMed ID: 6879516
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoimmunity and suppressor T lymphocytes.
    Miller KB; Schwartz RS
    Adv Intern Med; 1982; 27():281-313. PubMed ID: 7041545
    [No Abstract]   [Full Text] [Related]  

  • 33. [Principles of immunoregulation in autoimmune syndromes].
    Skotnicki AB
    Postepy Hig Med Dosw; 1983; 37(4):345-87. PubMed ID: 6233544
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunosuppressive therapy in autoimmune diseases].
    Schwarz-Eywill M
    Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):93-100. PubMed ID: 10355057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased CCR4 expression in active systemic lupus erythematosus.
    Hase K; Tani K; Shimizu T; Ohmoto Y; Matsushima K; Sone S
    J Leukoc Biol; 2001 Nov; 70(5):749-55. PubMed ID: 11698495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymosin administration in autoimmune disorders.
    Lavastida MT; Goldstein AL; Daniels JC
    Thymus; 1981 Feb; 2(4-5):287-95. PubMed ID: 6972106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis, diagnosis and therapy of transitional (presystemic) forms of lupus erythematosus].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1981 Nov; (11):4-7. PubMed ID: 6976049
    [No Abstract]   [Full Text] [Related]  

  • 38. Dendritic cells: potential triggers of autoimmunity and targets for therapy.
    Hardin JA
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv86-90. PubMed ID: 16239396
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in the cellular-humoral immune reactivity of patients with lupus nephritis and chronic glomerulonephritis treated with corticosteroids or corticosteroids and imuran].
    Stefanova G; Mikhaĭlova A; Gavrilov G; Naumova E; Bŭchvarova E
    Vutr Boles; 1983; 22(5):65-71. PubMed ID: 6673336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and basic science implications of autoimmunity and autoimmune disease.
    Talal N
    Recomb DNA Tech Bull; 1981 Sep; 4(3):116-7. PubMed ID: 7280289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.